Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. La HAS
  2. Agenda
  3. CEDiag du 11 mars 2025
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • Voir aussi
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print
11/03/2025

CEDiag du 11 mars 2025

Ordre du jour CEDiag et compte-rendu
Calendar Event - Posted on Apr 11 2025

Commission

icone hours 09h - 13h

Documents

  • ODJ CEDiag 20250311 VD MeL Xvox
  • CR CEDiag 2025 03 11 VD MeL Xvox

Contact Us

Évaluation des actes professionnels
  • Contact Us

See also

Web page
07/04/2023
Commission d’évaluation des technologies de santé diagnostiques, pronostiques et prédictives (CEDiag)

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
KV7N1a4RuEeCqaKT